ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 996,64
0,49%
Dow Jones
38 852,27
0,46%
DAX
18 175,21
1,01%
Brent Oil
83,345
0,26%
Bitcoin
63 464,42
-0,84%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Kiora Pharmaceuticals Inc (KPRX)

  7. Kiora Pharmaceuticals Inc (KPRX) Actualités

KPRX Kiora Pharmaceuticals Inc

0,521
0,0077 (1,50%)
Après les heures de négociation
Dernière mise à jour : 22:49:41
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Kiora Pharmaceuticals Inc KPRX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0077 1,50% 0,521 22:49:41
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,499 0,471 0,53749 0,521 0,5133
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
28/2/202422:40EDGAR2Form S-3 - Registration statement under Securities Act of..
14/2/202422:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202421:51EDGAR2Form D - Notice of Exempt Offering of Securities
14/2/202402:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202423:23EDGAR2Form 8-K - Current report
09/2/202422:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202416:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202413:01EDGAR2Form 8-K - Current report
31/1/202423:14EDGAR2Form 8-K - Current report
16/1/202423:16EDGAR2Form 8-K - Current report
09/11/202313:02EDGAR2Form 8-K - Current report
09/11/202313:01EDGAR2Form 8-K - Current report
09/11/202313:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202312:05EDGAR2Form 8-K - Current report
13/10/202323:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/10/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202313:00EDGAR2Form 8-K - Current report
01/9/202313:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/9/202313:00EDGAR2Form 8-K - Current report
10/8/202323:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/8/202313:14EDGAR2Form 8-K - Current report
08/8/202313:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202313:00EDGAR2Form 8-K - Current report
21/7/202322:49EDGAR2Form DEF 14A - Other definitive proxy statements
20/7/202323:01EDGAR2Form 8-K - Current report
11/7/202323:00EDGAR2Form PRE 14A - Other preliminary proxy statements
23/6/202314:35GLOBELife Science Investor Forum: Presentations Now Available for..
20/6/202316:58GLOBELife Science Investor Forum Agenda Announced for June 22nd

Dernières Valeurs Consultées

NASDAQ
KPRX
Kiora Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés